Highlights

Stock Price Target

 
Search
Recent Price Targets: [Sign In or Register (FREE) to view]
 
KLSE: AHEALTH       APEX HEALTHCARE BHD
Last Price Avg Target Price   Upside/Downside Price Call
3.75 2.84     -0.91 (24.27%)
* Average Target Price, Price Call and Upside/Downside are derived from Price Targets in the past 6 months.
** Price Targets are adjusted for Bonus Issue, Shares Split & Shares Consolidation (where applicable).
Date Open Price Target Price Upside/Downside Price Call Source News
23/11/2020 3.70 3.80 +0.10 (2.70%) HOLD AffinHwang Price Target News
20/11/2020 3.60 2.36 -1.24 (34.44%) SELL PUBLIC BANK Price Target News
27/08/2020 3.72 2.45 -1.27 (34.14%) HOLD PUBLIC BANK Price Target News
27/08/2020 3.72 2.75 -0.97 (26.08%) SELL AffinHwang Price Target News


Price Target Research Article/News (past 6 months)
23/11/2020  AffinHwang Company Update - Apex Healthcare - Upgrading to HOLD
20/11/2020  PUBLIC BANK Apex Healthcare Berhad - Uncertainties Ahead
27/08/2020  PUBLIC BANK Apex Healthcare Berhad- No Surprises
27/08/2020  AffinHwang Apex Healthcare - Earnings Holding Up Well



  4 people like this.
 
enigmatic [control your emotions, discipline your mind] Then write an analysis report which is better than hers to "teach" her. Empty cans make the most noise.
27/08/2020 10:45 AM
chshzhd cheaper than dpharma ..
28/08/2020 10:46 AM
chshzhd Just a myth. Contrary to popular belief, pharmaceutical companies like ApexH are also faced with an uncertain outlook for 2H2020 due to disruptions caused by the pandemic. Weaker consumer sentiment and cautious spending has impacted ApexH’s sales, while the deferment elective medical procedures like orthopaedic surgeries has resulted in lower demand for Straits Apex’s orthopaedic devices. However, during this tough time, ApexH has also completed its cold chain distribution expansion in Singapore, while the expansion in Malaysia is expected to complete in 4QFY20. Given that cold chain distribution is vital for the distribution of vaccine, we are positive on this timely expansion as ApexH would be able to expand into vaccine distribution, be it a Covid-19 vaccine or other vaccines available. However, contrary to market’s belief, we are not expecting immediate benefit arising from any potential vaccine distribution by Apex
Source: PublicInvest Research - 27 Aug 2020
28/08/2020 10:37 PM
LiimInvest Growing & Fundamental
29/08/2020 11:06 PM
mayongzheng https://youtu.be/eIgQAOLapj8
01/09/2020 8:54 PM
Wilfred51a https://news.cgtn.com/news/2020-09-11/Hundreds-of-thousands-have-been-given-Chinese-COVID-19-vaccines-THnoo6BcFG/index.html
12/09/2020 8:29 PM
Benlee88888 https://www.klsescreener.com/v2/news/view/728195
15/09/2020 9:33 PM
Benlee88888 Ini kali lah
15/09/2020 9:33 PM
LiimInvest Next TP over 5.00
15/09/2020 10:41 PM
GorengHealthcare joined to goreng
16/09/2020 10:01 PM
humongainz brother goreng oil la healthcare how can use for goreng aiyaiyai
16/09/2020 10:03 PM
hahasong United States vaccine failed!

The glove unit ESCERAM 0100 is about to fly!
17/09/2020 9:33 AM
Wilfred51a https://www.theedgemarkets.com/article/malaysia-join-covax-vaccine-plan
20/09/2020 7:50 PM
Alfonso jom nasi goreng to the best of the best
25/09/2020 4:29 PM
LiimInvest 吉隆坡1日讯)紧随政府的疫苗采购有进展,驱动大马股市的疫苗概念股在10月第一个交易日纷纷上涨。

发马联合药业受激励

受政府委定为疫苗灌封商的发马(PHARMA,7081,主板医疗保健组)受消息激励,闭市涨38仙(8.8%)至4令吉70仙;联合药业(DPHARMA,7148,主板医疗保健组)起32仙(10.1%)至3令吉48仙,双双跻身10大上涨股。

上述两股皆以接近最高与最高收市,发马成交量176万7600股,联合药业1629万6500股成交。

另一医疗保健股艾柏士保健(AHEALTH,7090,主板医疗保健组)涨9仙至3令吉33仙。

他说,政府通过多种管道和层面去洽谈采购疫苗,并希望越快越好。

“一旦获得卫生部旗下的大马药剂监管局(NPRA)批准,我国尽量在最短的时间内取得或购买冠病疫苗。”
01/10/2020 11:45 PM
50Cents Post removed. Why?
08/10/2020 1:22 AM
NPRA1985 How are the fundamentals of this stock? Good or bad?
25/10/2020 12:22 AM
LiimInvest Very Good fundamental
28/10/2020 12:10 AM
NPRA1985 Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December

“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”

https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
07/11/2020 2:31 AM
serendipity89 https://www.malaymail.com/news/malaysia/2020/11/10/buying-covid-19-vaccines-not-so-quick-as-no-infrastructure-yet-dr-noor-hish/1921347

Ahealth management has good business sense. Getting ready cold chain in sg and msia to distribute vaccine.
10/11/2020 10:10 PM
NPRA1985 Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml
10/11/2020 11:54 PM
NPRA1985 Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml
11/11/2020 12:07 AM
serendipity89 https://www.theedgemarkets.com/article/apex-healthcare-ready-play-role-vaccine-distribution
11/11/2020 8:48 AM
JaBerry People jump to vaccine company. Do we realise without supply chain and logistics also problem? Apex play important roles and has facilities and temperature control in distributing the vaccine.
11/11/2020 9:52 AM
NPRA1985 China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.

In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».

We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK

https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html
13/11/2020 9:54 PM
Sinoboy If moderna vaccine is for real, apex health can play a substantial role. Apparently, moderna's vaccine requires storage of only -20C. This is exactly what apex health has, storage facilities that meet this requirement.
Hopefully, such important information is not lost on the public. This counter has great potential
16/11/2020 8:17 PM
Russell Eventually vaccine makers will need to come to Apex Healthcare for its cold chain facility which will be completed in Q4. It just completed it’s cold chain in Singapore. Perfect stock for the recovery trend
16/11/2020 9:13 PM
Sinoboy Hopefully today's uptrend can be maintained...
19/11/2020 6:13 PM
serendipity89 profit seems to have recovered back to pre covid level. next to see is after they completed their cold chain network, whehter they are able to secure distribution contract for the vaccine.
19/11/2020 7:46 PM
LiimInvest Apex Pharma

On 14th September, the Group’s wholly owned manufacturing subsidiary Xepa-Soul Pattinson (M) Sdn Bhd secured renewal of its GMP status with the National Pharmaceutical Regulatory Authority (‘NPRA’) through a scheduled desktop audit. In the quarter, Apex Pharma Marketing Pte Ltd in Singapore increased its cold chain distribution capabilities with the expansion of its current 2-8 degrees C cold room and the acquisition of a -20 degrees C freezer room for pharmaceuticals, vaccines and biologics. Expansion of cold chain distribution capacity in Malaysia is scheduled for completion before the end of the current financial year.
Review of Year To Date Performance versus Corresponding Period Last Year
20/11/2020 12:05 AM
20/11/2020 12:06 AM
DreamGuardian Up 8 sen
20/11/2020 12:06 AM
DreamGuardian Up 2.27%
20/11/2020 12:06 AM
DreamGuardian Okay also la
20/11/2020 12:07 AM
DreamGuardian Boleh juga la
20/11/2020 12:07 AM
DreamGuardian Keep surging
20/11/2020 12:07 AM
DreamGuardian Good luck
20/11/2020 12:07 AM
LiimInvest Tomorrow Fly over 4.50
20/11/2020 12:10 AM
LiimInvest Accumulating more
20/11/2020 12:20 AM
Sinoboy Looking good. Steady she goes, don't falter
20/11/2020 11:52 AM
chshzhd keep..
20/11/2020 4:59 PM
JaBerry Yes keep
23/11/2020 9:22 AM
NPRA1985 Post removed. Why?
23/11/2020 2:00 PM
JaBerry Waiting for vaccines come another distribution income.
27/11/2020 9:36 AM
mrmeow AHEALTH has the cold storage facility and has expanded by acquiring more cold facility and prepared for the covid19 vaccines. Don't foget this real making money one, supplying Msia and Singapore, stable & growing business even before covid, always on an uptrend
27/11/2020 9:41 AM
mrmeow Everyone looking for logistics company that has cold facility for vaccine distribution, yet they forget that this pharmaceutical company does distribution too and has the logistics capable of doing the real work
27/11/2020 12:00 PM
LiimInvest Vaccine-related: Following the approval of Budget 2021, vaccine-related companies will benefit under the Covid-19 fund/fill-and-finish process as well as distribution of vaccines once it is available in the future. Under this segment, SOLUTN, HWGB, BINTAI, DPHARMA, PHARMA, KANGER, -Ahealth, TITIJYA, MAHSING should be under traders radar.

Source: M+ Online
27/11/2020 12:47 PM
serendipity89 ''Apex has been approached by several manufacturers to be the authorised distributor for their upcoming Covid-19 vaccines (work-in-progress). There are many considerations in evaluating these proposals (ie. whether the products will be approved, pricings, efficiencies, requirements, etc) and hence, Apex has not committed to any manufacturer. Instead, the group will likely start off as a wholesaler, where Apex will distribute the Covid-19 vaccines from various manufacturers''

AffinHWang
28/11/2020 1:30 PM
NPRA1985 PM: No call to reject 2021 Budget just to bring about polls

"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.

"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.

Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.

"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."

https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-2021-budget-just-bring-about-polls
29/11/2020 9:25 PM
NPRA1985 No significant change to reject budget at committee level: Dr M

FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.

“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.

“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.

https://themalaysianreserve.com/2020/11/27/no-significant-change-to-reject-budget-at-committee-level-dr-m/
29/11/2020 9:36 PM

APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 

2170 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SCOMNET 2.060.00 
 KOTRA 3.100.00 
 UCREST 0.150.00 
 GENM-C73 0.0050.00 
 PUC 0.150.00 
 WILLOW 0.4350.00 
 EAH-WE 0.0150.00 
 IRIS 0.350.00 
 TOPGLOV-C79 0.2250.00 
 BTECH 0.500.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!
PARTNERS & BROKERS